BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16889487)

  • 1. Fractional allelic loss of tumor suppressor genes identifies malignancy and predicts clinical outcome in follicular thyroid tumors.
    Hunt JL; Yim JH; Carty SE
    Thyroid; 2006 Jul; 16(7):643-9. PubMed ID: 16889487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness.
    Hunt JL; Livolsi VA; Baloch ZW; Swalsky PA; Bakker A; Sasatomi E; Finkelstein S; Barnes EL
    Hum Pathol; 2003 Apr; 34(4):375-80. PubMed ID: 12733119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors.
    Hunt JL; Yim JH; Tometsko M; Finkelstein SD; Swalsky P; Carty SE
    Surgery; 2003 Dec; 134(6):1043-7; discussion 1047-8. PubMed ID: 14668739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
    Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
    Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
    Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
    Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss.
    Tung WS; Shevlin DW; Kaleem Z; Tribune DJ; Wells SA; Goodfellow PJ
    Genes Chromosomes Cancer; 1997 May; 19(1):43-51. PubMed ID: 9135994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.
    Weber F; Aldred MA; Morrison CD; Plass C; Frilling A; Broelsch CE; Waite KA; Eng C
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1149-55. PubMed ID: 15546898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
    Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
    Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor gene allelic loss profiles of the variants of papillary thyroid carcinoma.
    Hunt JL; Fowler M; Lomago D; Niehouse L; Sasatomi E; Swalsky P; Finkelstein S
    Diagn Mol Pathol; 2004 Mar; 13(1):41-6. PubMed ID: 15163008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms.
    Matsuo K; Tang SH; Fagin JA
    Mol Endocrinol; 1991 Dec; 5(12):1873-9. PubMed ID: 1791835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
    Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
    Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
    Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
    Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
    Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
    Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.
    Schulte KM; Staudt S; Niederacher D; Finken-Eigen M; Köhrer K; Goretzki PE; Röher HD
    Horm Metab Res; 1998 Sep; 30(9):549-54. PubMed ID: 9808321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic instabilities of thyroid and colon cancers.
    Stoler DL; Nowak NJ; Matsui S; Wiseman SM; Chen N; Dutt SS; Bartos JD; Loree TR; Rigual NR; Hicks WL; Sait SN; Anderson GR
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):457-63. PubMed ID: 17515504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
    Ward LS; Brenta G; Medvedovic M; Fagin JA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.